CVR: 33761201
Previous names: NOVO NORDISK REGION NORTH AMERICA II A/S, Novo Nordisk Invest 3 A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at besidde ejerandele i selskaber i ind- og udland, at foretage investerings- og finansieringsvirksomhed, herunder anbringelse af kapital i virksomheder og fast ejendom i ind- og udland samt efter bestyrelsens nærmere bestemmelse at servicere sådanne selskaber og virksomheder driftsmæssigt. Selskabets formål er tillige at understøtte Novo Nordisk A/S farmaceutiske aktivitet. Selskabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | -74.1 mio. | 1.2 mia. | 60 mio. | 0 | |
| 2024 | - | -89.2 mio. | 1.3 mia. | 438.3 mio. | - | |
| 2023 | 0 | 1.1 mia. | 1.8 mia. | 1.1 mia. | - | |
| 2022 | 31.3 mio. | 334.3 mio. | 1 mia. | 639.2 mio. | - | |
| 2021 | 188.9 mio. | -467 mio. | 9.6 mia. | 7.8 mia. | - | |
| 2020 | - | 34.8 mio. | 11 mia. | 9.2 mia. | - | |
| 2019 | - | 189.9 mio. | 728.8 mio. | 728.5 mio. | - | |
| 2018 | - | 730 t. | 23.2 mio. | 3.4 mio. | - | |
| 2017 | - | -2.4 mio. | 88.7 mio. | 2.7 mio. | - | |
| 2016 | - | -5.3 mio. | 77.2 mio. | 25.1 mio. | - | |
| 2015 | - | -5.7 mio. | 49.2 mio. | 40.6 mio. | - | |
| 2014 | - | -21 t. | 459 t. | 424 t. | - | |
| 2013 | - | -27 t. | 521 t. | 445 t. | - | |
| 2012 | - | -17 t. | 513 t. | 472 t. | - |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 20.821 companies in Anden finansiel formidling i.a.n.
Comparison is based on industry median values
Novo Nordisk North America Operations A/S has published its annual report for 2025. Gross profit came to DKK -59,000, and the net result was DKK -74,142,000.
Contact info changed: new phone: 44448888 (May 13, 2026).
As of May 12, 2026, Anders Rytter Mikkelsen is registered as director of Novo Nordisk North America Operations A/S.
As of May 12, 2026, Peter Bøggild has stepped down as director of Novo Nordisk North America Operations A/S.
As of December 8, 2025, Naja Eilers Barrisøe has joined the board of directors of Novo Nordisk North America Operations A/S.
As of December 8, 2025, Karsten Munk Knudsen has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2024. Gross profit came to DKK -119,000, and the net result was DKK -89,167,000.
Novo Nordisk North America Operations A/S has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 1,092,811,000.
As of May 23, 2024, John Francis Kuckelman has joined the board of directors of Novo Nordisk North America Operations A/S.
As of May 23, 2024, Kristine Aachmann Bethe has left the board of directors of Novo Nordisk North America Operations A/S.
As of June 30, 2023, Kristine Aachmann Bethe has joined the board of directors of Novo Nordisk North America Operations A/S.
As of June 30, 2023, Tomas Haagen has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2022. Revenue came to DKK 31,296,000, and the net result was DKK 334,269,000.
Novo Nordisk North America Operations A/S has published its annual report for 2021. Revenue came to DKK 188,931,000, and the net result was DKK -467,036,000.
Novo Nordisk North America Operations A/S has published its annual report for 2020. The net result was DKK 34,830,000.
As of May 12, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Novo Nordisk North America Operations A/S.
As of May 12, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Novo Nordisk North America Operations A/S.
As of December 15, 2020, Linette Tangsgaard Nielsen has joined the board of directors of Novo Nordisk North America Operations A/S.
As of December 15, 2020, Lene Moth Bang has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2019. The net result was DKK 189,945,000.
On November 29, 2019, the company changed its name from Novo Nordisk Invest 3 A/S to Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2018. The net result was DKK 730,000.
As of October 1, 2018, Tomas Haagen has joined the board of directors of Novo Nordisk North America Operations A/S.
As of October 1, 2018, Ole Falvig Ramsby has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2017. The net result was DKK -2,394,000.
As of April 25, 2018, Karsten Munk Knudsen has joined the board of directors of Novo Nordisk North America Operations A/S.
As of April 25, 2018, Jesper Brandgaard has left the board of directors of Novo Nordisk North America Operations A/S.
As of April 25, 2018, Peter Bøggild is registered as director of Novo Nordisk North America Operations A/S.
As of April 25, 2018, Karsten Munk Knudsen has stepped down as director of Novo Nordisk North America Operations A/S.
As of June 1, 2017, Lene Moth Bang has joined the board of directors of Novo Nordisk North America Operations A/S.
As of June 1, 2017, Lars Fruergaard Jørgensen has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2016. The net result was DKK -5,342,000.
Novo Nordisk North America Operations A/S has published its annual report for 2015. The net result was DKK -5,714,000.
On August 17, 2015, the company changed its name from NOVO NORDISK REGION NORTH AMERICA II A/S to Novo Nordisk Invest 3 A/S.
As of April 30, 2015, Lars Fruergaard Jørgensen has joined the board of directors of Novo Nordisk North America Operations A/S.
As of April 30, 2015, Kåre Schultz has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2014. The net result was DKK -21,000.
As of July 1, 2014, Karsten Munk Knudsen is registered as director of Novo Nordisk North America Operations A/S.
As of July 1, 2014, Lars Green has stepped down as director of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2013. The net result was DKK -27,000.
Novo Nordisk North America Operations A/S has published its annual report for 2012. The net result was DKK -17,000.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Novo Nordisk North America Operations A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of Novo Nordisk North America Operations A/S.
As of June 14, 2011, A/S PSE NR. 4820 has been appointed auditor of Novo Nordisk North America Operations A/S.
As of June 14, 2011, Kåre Schultz has joined the board of directors of Novo Nordisk North America Operations A/S.
As of June 14, 2011, Ole Falvig Ramsby has joined the board of directors of Novo Nordisk North America Operations A/S.
As of June 14, 2011, Jesper Brandgaard has joined the board of directors of Novo Nordisk North America Operations A/S.
As of June 14, 2011, Lars Green is registered as director of Novo Nordisk North America Operations A/S.
As of June 14, 2011, NOVO NORDISK A/S is registered as an owner of Novo Nordisk North America Operations A/S with an ownership share of 100%.
Novo Nordisk North America Operations A/S was founded on June 14, 2011.
Companies in the same industry and area
CVR 21244643
CVR 43221124
CVR 36951982
CVR 34055467
CVR 16257281
companydata.dk